26-Year-Old Woman with Rare and Life-Threating Pregnancy Tumour successfully treated at Fortis Hospital Nagarbhavi

▴ Fortis Hospital Nagarbhavi
Rare Pregnancy Tumors are reported in 2 out of every 1000 Pregnancies.

Bengaluru, 15 January 2026: Doctors at Fortis Hospital, Nagarbhavi successfully treated a Life-threatening pregnancy-related tumour in a 26-year-old woman, while preserving her uterus and fertility. The patient was diagnosed with Gestational Trophoblastic Neoplasia - a rare pregnancy-related tumour characterized by abnormal tissue growth inside the uterus. The tumor posed a high risk of sudden, severe internal bleeding if not handled with extreme caution. The rare case was managed through a multi-disciplinary approach led by Dr. Nirmala Chandrashekar, Consultant – Obstetrics & Gynaecology, Fortis Hospital, Nagarbhavi.

When admitted at Fortis Nagarbhavi, the patient was presented with complaints of missed abortion (a type of miscarriage where the pregnancy has stopped developing) and continuous vaginal spotting. Her ultrasound scans showed abnormal intrauterine mass with significantly increased blood flow. In such cases, emergency removal of the uterus becomes necessary to save the patient’s life. Given the gravity of the situation, the patient’s family initially requested hysterectomy. However, after thorough evaluation, the Fortis Nagarbhavi medical team opted for a carefully planned, step-by-step conservative approach aimed at preserving the patient’s fertility.

The team of doctors, first performed a procedure to temporarily block blood supply to the uterus, significantly reducing the risk of massive bleeding. This was followed by a meticulously monitored removal of the abnormal tissue under ultrasound guidance. The patient responded well to the treatment, experienced no major complications, and recovered smoothly. Subsequent tests confirmed a partial molar pregnancy, a rare but treatable condition. After treatment, the patient’s pregnancy hormone levels returned to normal, confirming complete recovery without the need for uterus removal.

Giving details of the case, Dr Nirmala ChandrashekarConsultant – Obstetrics & Gynaecology, Fortis Hospital, Nagarbhavi said, “This was an extremely challenging case due to the high risk of sudden and severe bleeding. Our foremost priority was to save the patient’s life while making every possible effort to preserve her uterus. By carefully reducing uterine blood flow first and then removing the abnormal tissue under ultrasound guidance, we were able to achieve a safe and fertility-preserving outcome.”

Expressing her gratitude, the patient said, “I feared the worst, but I never imagined it could be so serious. The doctors at Fortis Nagarbhavi explained everything patiently and treated me with great care. I am deeply grateful that my life was saved and that my ability to have children in the future has been conserved.”

Mr Ratheef Naik, Facility Director, Fortis Hospital, Nagarbhavi, added, “Gestational trophoblastic tumours demand early diagnosis and coordinated multidisciplinary expertise. At Fortis Nagarbhavi, we are equipped to deliver advanced, conservative and fertility-preserving care when patients seek timely treatment. This successful intervention once again reinforces our position as a leading tertiary care centre for managing high-risk and complex obstetric conditions, combining clinical excellence with compassionate, patient-centric care.”

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026